Skip to main content

Table 1 Pateint Data

From: Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases

Baseline characteristics

ILD

N = 23

Donor explant controls

N = 9

Time FVC% to biopsy (months)

Age (years ± SD)

60 ± 9.8

50 ± 7.8

 

Sex (male, N %)

13 (57%)

4 (44%)

 

Race

   

 White

18

7

 

 Black

5

2

 

Type of interstitial lung disease (N, (%))

   

 Connective tissue disease

12 (52)

 

2.25 \(\pm 1.75\)

 Unclassifiable

6 (26)

 

2.83 \(\pm 1.20\)

 Smoking-related

4 (17)

 

1.55 \(\pm 0.95\)

Hypersensitivity pneumonitis

1 (4)

 

1.8